nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2A—conduct disorder	0.864	1	CbGaD
Oxymetazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00058	0.00428	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000574	0.00424	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000571	0.00422	CbGpPWpGaD
Oxymetazoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000545	0.00402	CbGpPWpGaD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000507	0.00374	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.000498	0.00367	CbGpPWpGaD
Oxymetazoline—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000489	0.00361	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000458	0.00338	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—CGA—conduct disorder	0.000451	0.00333	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—CGA—conduct disorder	0.000442	0.00326	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00044	0.00324	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000428	0.00316	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000421	0.00311	CbGpPWpGaD
Oxymetazoline—HTR1D—G alpha (i) signalling events—DRD4—conduct disorder	0.000417	0.00308	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—CGA—conduct disorder	0.000415	0.00306	CbGpPWpGaD
Oxymetazoline—HTR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.000409	0.00302	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000397	0.00293	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000387	0.00286	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.000386	0.00285	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000382	0.00282	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000379	0.0028	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—CGA—conduct disorder	0.000376	0.00278	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000374	0.00276	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000373	0.00275	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR ligand binding—DRD4—conduct disorder	0.000373	0.00275	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000356	0.00263	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.000349	0.00257	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000347	0.00256	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—CGA—conduct disorder	0.000342	0.00252	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000335	0.00247	CbGpPWpGaD
Oxymetazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000332	0.00245	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000331	0.00245	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.000326	0.0024	CbGpPWpGaD
Oxymetazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000325	0.0024	CbGpPWpGaD
Oxymetazoline—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.000322	0.00238	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.000321	0.00237	CbGpPWpGaD
Oxymetazoline—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000319	0.00236	CbGpPWpGaD
Oxymetazoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000305	0.00225	CbGpPWpGaD
Oxymetazoline—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.000301	0.00222	CbGpPWpGaD
Oxymetazoline—HTR2B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000301	0.00222	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000299	0.00221	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000299	0.0022	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000291	0.00215	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000287	0.00212	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000285	0.0021	CbGpPWpGaD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000284	0.0021	CbGpPWpGaD
Oxymetazoline—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00028	0.00206	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00028	0.00206	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000275	0.00203	CbGpPWpGaD
Oxymetazoline—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000269	0.00198	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000265	0.00195	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000256	0.00189	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—CGA—conduct disorder	0.000255	0.00188	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000253	0.00186	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—DRD4—conduct disorder	0.000253	0.00186	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00025	0.00185	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.00025	0.00184	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00025	0.00184	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000247	0.00183	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.000247	0.00183	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000246	0.00182	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000245	0.00181	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000244	0.0018	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR ligand binding—HTR2A—conduct disorder	0.000243	0.00179	CbGpPWpGaD
Oxymetazoline—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000243	0.00179	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00024	0.00177	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000236	0.00174	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000235	0.00173	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000232	0.00172	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000232	0.00172	CbGpPWpGaD
Oxymetazoline—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000232	0.00171	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.000232	0.00171	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000227	0.00168	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.000227	0.00167	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.000218	0.00161	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000217	0.0016	CbGpPWpGaD
Oxymetazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000217	0.0016	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000216	0.0016	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.000216	0.0016	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000214	0.00158	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000213	0.00157	CbGpPWpGaD
Oxymetazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000212	0.00156	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—DRD4—conduct disorder	0.000211	0.00155	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000209	0.00155	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000208	0.00153	CbGpPWpGaD
Oxymetazoline—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000206	0.00152	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CGA—conduct disorder	0.000202	0.00149	CbGpPWpGaD
Oxymetazoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000199	0.00147	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.000198	0.00146	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000197	0.00145	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000195	0.00144	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000195	0.00144	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000195	0.00144	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—DRD4—conduct disorder	0.000191	0.00141	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000189	0.0014	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000188	0.00138	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000188	0.00138	CbGpPWpGaD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000185	0.00137	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000184	0.00136	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.000184	0.00136	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000182	0.00135	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.000182	0.00135	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000181	0.00134	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00018	0.00132	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000179	0.00132	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000179	0.00132	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000172	0.00127	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000167	0.00123	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.000167	0.00123	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	0.000165	0.00122	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000164	0.00121	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000164	0.00121	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000163	0.0012	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—WASF1—conduct disorder	0.000162	0.00119	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	0.000161	0.00119	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000161	0.00119	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000161	0.00119	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000159	0.00118	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000159	0.00118	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000156	0.00115	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000154	0.00113	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	0.000152	0.00112	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000149	0.0011	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000149	0.0011	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000148	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000148	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000146	0.00108	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	0.000143	0.00105	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.000141	0.00104	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	0.00014	0.00103	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—HTR2A—conduct disorder	0.000137	0.00101	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CGA—conduct disorder	0.000137	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000137	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000136	0.001	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CGA—conduct disorder	0.000134	0.000988	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	0.000131	0.000969	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—DRD4—conduct disorder	0.00013	0.000957	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000129	0.000952	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.000127	0.00094	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—DRD4—conduct disorder	0.000127	0.000937	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000127	0.000937	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CGA—conduct disorder	0.000126	0.000928	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—HTR2A—conduct disorder	0.000125	0.000921	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000122	0.000903	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.000122	0.000902	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—DRD4—conduct disorder	0.000119	0.00088	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.000119	0.000878	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—CGA—conduct disorder	0.000118	0.000871	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000117	0.000864	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.000117	0.000864	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD4—conduct disorder	0.000113	0.000834	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.000111	0.000819	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.00011	0.000814	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—WASF1—conduct disorder	0.00011	0.000809	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—WASF1—conduct disorder	0.000107	0.000792	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	0.000106	0.000782	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.000106	0.00078	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000104	0.000768	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.000103	0.000761	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CGA—conduct disorder	0.000102	0.000749	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000101	0.000749	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—WASF1—conduct disorder	0.000101	0.000744	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.0001	0.000739	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CGA—conduct disorder	9.87e-05	0.000729	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CGA—conduct disorder	9.72e-05	0.000717	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	9.67e-05	0.000713	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD4—conduct disorder	9.62e-05	0.00071	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—CGA—conduct disorder	9.59e-05	0.000708	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—WASF1—conduct disorder	9.38e-05	0.000692	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	9.36e-05	0.000691	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	9.32e-05	0.000688	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	9.21e-05	0.00068	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	9.2e-05	0.000679	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	9.12e-05	0.000673	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	9.01e-05	0.000665	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CGA—conduct disorder	8.81e-05	0.00065	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CGA—conduct disorder	8.63e-05	0.000637	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	8.57e-05	0.000632	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—WASF1—conduct disorder	8.47e-05	0.000625	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	8.46e-05	0.000624	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	8.37e-05	0.000618	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD4—conduct disorder	8.36e-05	0.000617	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	8.28e-05	0.000611	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	8.18e-05	0.000604	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—WASF1—conduct disorder	8.14e-05	0.0006	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CGA—conduct disorder	8.02e-05	0.000592	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	7.97e-05	0.000588	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—WASF1—conduct disorder	7.91e-05	0.000584	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—WASF1—conduct disorder	7.79e-05	0.000575	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	7.78e-05	0.000574	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD4—conduct disorder	7.66e-05	0.000565	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	7.6e-05	0.000561	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD4—conduct disorder	7.5e-05	0.000554	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—HTR2A—conduct disorder	7.37e-05	0.000544	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	7.24e-05	0.000534	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	7.2e-05	0.000531	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.06e-05	0.000521	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD4—conduct disorder	7.05e-05	0.00052	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—WASF1—conduct disorder	6.92e-05	0.00051	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	6.91e-05	0.00051	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	6.72e-05	0.000496	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	6.62e-05	0.000488	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD4—conduct disorder	6.56e-05	0.000484	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	6.54e-05	0.000482	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—WASF1—conduct disorder	6.43e-05	0.000474	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	6.28e-05	0.000463	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	6.11e-05	0.000451	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—EP300—conduct disorder	6.04e-05	0.000445	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	6.01e-05	0.000444	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD4—conduct disorder	5.92e-05	0.000437	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	5.88e-05	0.000434	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD4—conduct disorder	5.68e-05	0.000419	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—EP300—conduct disorder	5.64e-05	0.000416	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD4—conduct disorder	5.53e-05	0.000408	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	5.46e-05	0.000403	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD4—conduct disorder	5.44e-05	0.000402	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	5.34e-05	0.000394	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—COMT—conduct disorder	5.33e-05	0.000393	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—MAOA—conduct disorder	5.29e-05	0.000391	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HTR2A—conduct disorder	5e-05	0.000369	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	4.96e-05	0.000366	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.94e-05	0.000364	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HTR2A—conduct disorder	4.89e-05	0.000361	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD4—conduct disorder	4.83e-05	0.000357	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HTR2A—conduct disorder	4.6e-05	0.000339	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—EP300—conduct disorder	4.58e-05	0.000338	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD4—conduct disorder	4.49e-05	0.000331	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—COMT—conduct disorder	4.33e-05	0.000319	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—MAOA—conduct disorder	4.3e-05	0.000317	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	4.28e-05	0.000316	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EP300—conduct disorder	3.91e-05	0.000288	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	3.86e-05	0.000285	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.71e-05	0.000274	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	3.61e-05	0.000266	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	3.55e-05	0.000262	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	3.15e-05	0.000233	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	2.93e-05	0.000216	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EP300—conduct disorder	2.65e-05	0.000195	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EP300—conduct disorder	2.59e-05	0.000191	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EP300—conduct disorder	2.44e-05	0.00018	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—EP300—conduct disorder	2.29e-05	0.000169	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EP300—conduct disorder	2.27e-05	0.000167	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EP300—conduct disorder	2.05e-05	0.000151	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EP300—conduct disorder	1.96e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.91e-05	0.000141	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.88e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—EP300—conduct disorder	1.86e-05	0.000137	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EP300—conduct disorder	1.71e-05	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.67e-05	0.000123	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.55e-05	0.000115	CbGpPWpGaD
